theHeart.org: Lipid and Metabolic news related to heart conditions.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Bob Harrington

Nov 6, 2009 09:50 EST

Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.

Editorial series

Clinical research: Comparing regulatory pathways in US and UK

Oct 30, 2009 12:35 EDT

How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Peter Sleight

2 COMMENTS - Oct 13, 2009 10:15 EDT

With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.

Editorial series

ACC and AHA: Leadership in today's healthcare environment

Sep 15, 2009 14:10 EDT

Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.

The Cardiology Show

Best of Barcelona: PLATO and RE-LY

Sep 2, 2009 11:15 EDT

Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.

Editorial series

Getting to the bottom of BARI 2D

3 COMMENTS - Jun 25, 2009 00:03 EDT

Join Drs Valentin Fuster, William E Boden, and George D Dangas as they discuss the results, plus the evolution of therapy over the last forty years, the mechanisms of coronary artery disease progression in diabetic patients, and what is perhaps one of the most fundamental problems in the field: that patients today are still not treated to target with best medical therapy.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Steve Nissen

1 COMMENT - Jun 1, 2009 10:20 EDT

Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.

The Cardiology Show

ACC 2009: From the eye of the storm in Orlando

Apr 2, 2009 15:35 EDT

Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.

Editorial series

Lipid lowering: The end or the means?

4 COMMENTS - Dec 9, 2008 16:46 EST

Dr Blumenthal talks to Drs Krumholz, Ridker, and Smith about how to approach target guidelines for LDL in the wake of JUPITER, SEARCH, and other lipid-lowering studies.

Ten years in review

Reviewing 10 years of cardiology news

1 COMMENT - Dec 3, 2008 14:30 EST

As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?

Cardiology panels

Cardiovascular implications of treating type 2 diabetes, post-APPROACH

5 COMMENTS - Dec 3, 2008 09:30 EST

How best to treat patients presenting with both coronary disease and diabetes? Join Drs Nesto and Fonseca on this rather slippery slope as they examine the data and provide practical guidance for treatment.

The Cardiology Show

AHA 2008: The AHA Flies to JUPITER

3 COMMENTS - Nov 14, 2008 12:00 EST

Join Drs Krumholz, Blumenthal, Harrington, Jessup, Ridker, Smith, Stone, Weintraub, and Yancy as they dissect the results of the JUPITER and debate the far-reaching clinical implications of this landmark study in Part 1 of the program. In Part 2, the panelists look at the positive sides of HF-Action and TIMACS and deliberate the real lessons learned from these negative trials.

Cardiology panels

The media response to ENHANCE

Jun 2, 2008 14:22 EDT

Join heartwire's Larry Husten as he talks to Dr Harlan Krumholz and USA Today journalist Steve Sternberg about the decision to present the results of the ENHANCE trial at a unique opening session of the ACC 2008 Scientific Sessions, and about the response of the cardiology community and the media to the continuing controversy.

Dr Valentin Fuster

The Cardiology Show

Surrogate end points on trial: ENHANCE and other controversies

15 COMMENTS - Apr 4, 2008 16:35 EDT

Join Drs Valentin Fuster, Robert Harrington, Steven Nissen, Gregg Stone, Clyde Yancy, Gilles Montalescot, Keith Fox, Frans Van de Werf, and Harlan Krumholz for an upfront and spirited discussion as they thrash out the controversies surrounding ENHANCE and STRADIVARIUS, consider the results of ONTARGET and PERISCOPE, and question the utility of surrogate end points.

Thumbs up, thumbs down

Controversies: ENHANCE and ACCORD

Mar 28, 2008 17:00 EDT

Clinical trials are under attack and in the headlines. What are the proper roles of industry and academics? Who owns the data? Join two of the world's foremost experts on clinical trials in a lively discussion of the many controversial and thorny issues surrounding ENHANCE and ACCORD.

	Yes
	No